180 related articles for article (PubMed ID: 8481903)
1. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors.
Oyama F; Hirohashi S; Sakamoto M; Titani K; Sekiguchi K
Cancer Res; 1993 May; 53(9):2005-11. PubMed ID: 8481903
[TBL] [Abstract][Full Text] [Related]
2. Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues.
Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
Cancer Res; 1990 Feb; 50(4):1075-8. PubMed ID: 2297755
[TBL] [Abstract][Full Text] [Related]
3. Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues.
Oyama F; Murata Y; Suganuma N; Kimura T; Titani K; Sekiguchi K
Biochemistry; 1989 Feb; 28(3):1428-34. PubMed ID: 2713373
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin.
Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
Cancer Res; 1991 Sep; 51(18):4876-81. PubMed ID: 1716516
[TBL] [Abstract][Full Text] [Related]
5. Modulation of pre-mRNA splicing and protein production of fibronectin by TGF-beta2 in porcine trabecular cells.
Li J; Tripathi BJ; Tripathi RC
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3437-43. PubMed ID: 11006236
[TBL] [Abstract][Full Text] [Related]
6. Cloning of the mouse fibronectin V-region and variation of its splicing pattern in experimental immune complex glomerulonephritis.
Bergijk EC; Baelde HJ; Kootstra CJ; De Heer E; Killen PD; Bruijn JA
J Pathol; 1996 Apr; 178(4):462-8. PubMed ID: 8691328
[TBL] [Abstract][Full Text] [Related]
7. Expression, localization and alternative splicing pattern of fibronectin messenger RNA in fibrotic human liver and hepatocellular carcinoma.
Matsui S; Takahashi T; Oyanagi Y; Takahashi S; Boku S; Takahashi K; Furukawa K; Arai F; Asakura H
J Hepatol; 1997 Nov; 27(5):843-53. PubMed ID: 9382972
[TBL] [Abstract][Full Text] [Related]
8. Distribution of fibronectin isoforms in human renal disease.
Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
10. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the expression of the alternative splicing of the ED-A, ED-B and V regions of fibronectin mRNA in bovine ovarian follicles and corpora lutea.
De Candia LM; Rodgers RJ
Reprod Fertil Dev; 1999; 11(6):367-77. PubMed ID: 10972305
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
13. Differential splicing of fibronectin pre-messenger ribonucleic acid during cardiac ontogeny and development of hypertrophy in the rat.
Farhadian F; Barrieux A; Lortet S; Marotte F; Oliviero P; Rappaport L; Samuel JL
Lab Invest; 1994 Oct; 71(4):552-9. PubMed ID: 7967511
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of fibronectin transcripts in osteochondrogenic tumors.
Matsui Y; Nakata K; Araki N; Ozono K; Fujita Y; Tsumaki N; Kawabata H; Yasui N; Sekiguchi K; Yoshikawa H
Anticancer Res; 2001; 21(2A):1103-6. PubMed ID: 11396146
[TBL] [Abstract][Full Text] [Related]
15. Regulation of alternative splicing in the IIICS region of human fibronectin pre-mRNA encoding cell binding sites CS1 and CS5.
Mardon HJ; Sebastio G
J Cell Sci; 1992 Oct; 103 ( Pt 2)():423-33. PubMed ID: 1478944
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors.
Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
J Biol Chem; 1989 Jun; 264(18):10331-4. PubMed ID: 2543664
[TBL] [Abstract][Full Text] [Related]
17. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent differential expression of fibronectin variants in skin and airway mucosal wounds.
Li-Korotky HS; Hebda PA; Lo CY; Dohar JE
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):919-24. PubMed ID: 17875859
[TBL] [Abstract][Full Text] [Related]
19. Alternatively spliced isoforms of fibronectin in immune-mediated glomerulosclerosis: the role of TGFbeta and IL-4.
Baelde HJ; Eikmans M; van Vliet AI; Bergijk EC; de Heer E; Bruijn JA
J Pathol; 2004 Nov; 204(3):248-57. PubMed ID: 15372454
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin overexpression in retinal microvessels of patients with diabetes.
Roy S; Cagliero E; Lorenzi M
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):258-66. PubMed ID: 8603829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
